128 related articles for article (PubMed ID: 12810829)
1. Pathological assessment of intraductal spread of carcinoma in relation to surgical margin state in breast-conserving surgery.
Ishida T; Furuta A; Moriya T; Ohuchi N
Jpn J Clin Oncol; 2003 Apr; 33(4):161-6. PubMed ID: 12810829
[TBL] [Abstract][Full Text] [Related]
2. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
Ohuchi N; Furuta A; Mori S
Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
[TBL] [Abstract][Full Text] [Related]
3. [Intraductal spread of carcinoma: a risk for breast conserving surgery].
Ohuchi N; Furuta A; Mori S
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():183-9. PubMed ID: 8037480
[TBL] [Abstract][Full Text] [Related]
4. Multidetector row computed tomography for diagnosing intraductal extension of breast carcinoma.
Fujita T; Doihara H; Takabatake D; Takahashi H; Yoshitomi S; Ishibe Y; Ogasawara Y; Shimizu N
J Surg Oncol; 2005 Jul; 91(1):10-6. PubMed ID: 15999347
[TBL] [Abstract][Full Text] [Related]
5. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems.
Ohtake T; Abe R; Kimijima I; Fukushima T; Tsuchiya A; Hoshi K; Wakasa H
Cancer; 1995 Jul; 76(1):32-45. PubMed ID: 8630874
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of growth pattern and extension of tumor-associated intraductal carcinoma of the breast.
Eggemann H; Kalinski T; Ruhland AK; Ignatov T; Costa SD; Ignatov A
Clin Breast Cancer; 2015 Jun; 15(3):227-33. PubMed ID: 25516401
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
8. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.
Wazer DE; Schmidt-Ullrich RK; Schmid CH; Ruthazer R; Kramer B; Safaii H; Graham R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):291-9. PubMed ID: 9226315
[TBL] [Abstract][Full Text] [Related]
9. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.
Schnitt SJ; Abner A; Gelman R; Connolly JL; Recht A; Duda RB; Eberlein TJ; Mayzel K; Silver B; Harris JR
Cancer; 1994 Sep; 74(6):1746-51. PubMed ID: 8082077
[TBL] [Abstract][Full Text] [Related]
10. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
11. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer.
Jimenez RE; Bongers S; Bouwman D; Segel M; Visscher DW
Am J Surg Pathol; 2000 Jan; 24(1):123-8. PubMed ID: 10632496
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens.
Mai KT; Yazdi HM; Ford JC; Matzinger FR
Eur J Surg Oncol; 2000 Nov; 26(7):646-51. PubMed ID: 11078610
[TBL] [Abstract][Full Text] [Related]
14. Extent of margin involvement, lymphovascular invasion, and extensive intraductal component predict for residual disease after wide local excision for breast cancer.
Alrahbi S; Chan PM; Ho BC; Seah MD; Chen JJ; Tan EY
Clin Breast Cancer; 2015 Jun; 15(3):219-26. PubMed ID: 25576998
[TBL] [Abstract][Full Text] [Related]
15. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.
Holland R; Connolly JL; Gelman R; Mravunac M; Hendriks JH; Verbeek AL; Schnitt SJ; Silver B; Boyages J; Harris JR
J Clin Oncol; 1990 Jan; 8(1):113-8. PubMed ID: 2153190
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
van Deurzen CH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
[TBL] [Abstract][Full Text] [Related]
17. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
Gage I; Schnitt SJ; Nixon AJ; Silver B; Recht A; Troyan SL; Eberlein T; Love SM; Gelman R; Harris JR; Connolly JL
Cancer; 1996 Nov; 78(9):1921-8. PubMed ID: 8909312
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age.
Imamura H; Haga S; Shimizu T; Watanabe O; Kinoshita J; Nagumo H; Kajiwara T; Aiba M
Breast Cancer Res Treat; 2000 Aug; 62(3):177-84. PubMed ID: 11072782
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Residual Tumor in Breast-Conserving Therapy.
Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
